Under construction – not a live service
Sign in
Not yet taking people in FranceNo phase

Using Illusions to Boost Social Cognition

Key facts

Where
Bron, FranceSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 40 years old?

Source: NCT07602712, who can take part

Where in France

  • CH Le VinatierBron, FranceNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Hôpital le Vinatier
Trial code
NCT07602712
Record updated
22 May 2026
Original description
This study aims to explore whether the observation of complex visual objects can help improve social cognition in people living with psychotic disorders. Social cognition refers to the ability to understand what others think, feel, or intend, and plays a key role in social relationships and daily interactions.Read full original descriptionShow less

Socio-cognitive Benefits of Exposure to Visual Illusions in Patients With Psychotic Disorders

This study aims to explore whether the observation of complex visual objects can help improve social cognition in people living with psychotic disorders. Social cognition refers to the ability to understand what others think, feel, or intend, and plays a key role in social relationships and daily interactions.

Main questions this study aims to answer:

* Does dyadic exposure to complex visual objects improve mental state attribution, as measured by the Faux Pas Test? * Does the intervention enhance related domains of social cognition, including implicit intention inference (Hinting Task), interpretation of complex interactions (Movie for the Assessment of Social Cognition, MASC), and reduction of hostile attribution biases (Ambiguous Intentions Hostility Questionnaire, AIHQ)? * Are improvements maintained after one month, and do patients who receive the intervention later (waitlist group) show the same benefits once exposed?

Inclusion: Aged 18 to 40 years; Fluent French speaker; Has provided written informed consent; For individuals under guardianship (curatorship): inclusion is permitted if the curator is available to assist or advise when needed; Established diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, or brief psychotic disorder according to theDiagnostic and statistical manual of mental disorders (DSM-5-TR) criteria; Presence of social cognition impairment, defined by:subjective complaint reported by the participant or identified by care teams regarding difficulties in social interaction and clinical confirmation of observable difficulties (e.g., social withdrawal, misinterpretation of others' intentions, inappropriate social behaviour); Membership or entitlement to a social security plan.

Exclusion: Concurrent participation in another social cognition remediation program; Significant change in psychotropic medication within the past month; Uncorrectable visual impairment preventing participation; Clinical state incompatible with participation in group-based activities (e.g., severe psychomotor agitation, severe behavioural disturbance); Diagnosis of intellectual disability; Insufficient comprehension of French for verbal interaction and test completion; Pregnant women; Individuals under full guardianship (tutorship).

ClinicalTrials.gov NCT07602712